Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC)

Nicole R. Gonzales, Jharna Shah, Navdeep Sangha, Lenis Sosa, Rebecca Martinez, Loren Shen, Mallikarjunarao Kasam, Miriam M. Morales, M. Monir Hossain, Andrew D. Barreto, Sean I. Savitz, George Lopez, Vivek Misra, Tzu Ching Wu, Ramy El Khoury, Amrou Sarraj, Preeti Sahota, William Hicks, Indrani Acosta, M. Rick SlineMohammad H. Rahbar, Xiurong Zhao, Jaroslaw Aronowski, James C. Grotta

Research output: Contribution to journal › Article › peer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC)'. Together they form a unique fingerprint.

Medicine & Life Sciences